Oxymetazoline for Ptosis
JAMA Ophthalmol
.
2020 Nov 1;138(11):1176-1177.
doi: 10.1001/jamaophthalmol.2020.3833.
Authors
Elizabeth A Bradley
1
,
David J Bradley
2
Affiliations
1
Mayo Clinic Department of Ophthalmology, Mayo Foundation, Rochester, Minnesota.
2
Mayo Clinic Department of Cardiovascular Medicine, Mayo Foundation, Rochester, Minnesota.
PMID:
33001145
DOI:
10.1001/jamaophthalmol.2020.3833
No abstract available
Publication types
Comment
MeSH terms
Blepharoptosis* / chemically induced
Blepharoptosis* / diagnosis
Humans
Oxymetazoline* / adverse effects
Randomized Controlled Trials as Topic
Visual Fields
Substances
Oxymetazoline